Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trialAlexandre Mebazaa, Gad Cotter, Maria Novosadova et al.|The Lancet|2022Cited by 1k
Temporal trends in mortality and readmission after acute heart failure: a systematic review and meta‐regression in the past four decadesAntoine Kimmoun, Koji Takagi, Emmanuel Gall et al.|European Journal of Heart Failure|2021Cited by 109
Clinical Phenotypes of Acute Heart Failure Based on Signs and Symptoms of Perfusion and Congestion at Emergency Department Presentation and their Relationship with Patient Management and OutcomesPatricia Javaloyes, Pere Llorens, Òscar Miró et al.|European Journal of Heart Failure|2019Cited by 105
Circulating Dipeptidyl Peptidase 3 and Alteration in Haemodynamics in Cardiogenic Shock: Results from the OptimaCC TrialKoji Takagi, Antoine Kimmoun, Alice Blet et al.|European Journal of Heart Failure|2019Cited by 97
Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection FractionMatteo Pagnesi, Beth A. Davison, Marco Metra et al.|Journal of the American College of Cardiology|2023Cited by 72